Petros Fessas
Du Cane Road
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Impact of Immunotherapy Addition on Dose Density and Clinical Outcomes of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Retrospective, Real-world Study From Multiple Centers in London, UK.
Journal: Clinical breast cancer
Published: January 06, 2026
The safety and clinical impact of ultra-low-dose FDG-PET imaging in pregnancy-associated breast cancer: the experience of a major tertiary oncology referral centre in the UK and suggested imaging protocol.
Journal: Nuclear medicine communications
Published: June 04, 2025
Pathological complete response with cocktail chemotherapy in mediastinal seminoma.
Journal: BMJ case reports
Published: March 19, 2025
PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma.
Journal: Future oncology (London, England)
Published: April 25, 2023
Insights into the metastatic cascade through research autopsies.
Journal: Trends in cancer
Published: February 02, 2023
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: May 18, 2022
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: August 31, 2021
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
Journal: Hepatology communications
Published: August 03, 2021
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
Journal: Therapeutic advances in medical oncology
Published: December 20, 2020
Last Updated: 09/26/2026